71. Sanders CE, Julian BA, Gaston RS, Deierhoi MH, Diethelm AG, Curtis JJ: Benefits of continued cyclosporine through an indigent drug program. Am J Kidney Dis 28:572–577, 1996.

72. Lagnado, L. Transplant patients ply an illicit market for vital medicines. Wall Street Journal, 6/21/99, p. 1.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement